Increasing evidence has suggested that cholecystokinin (CCK) is involved in immune-to-brain communication. The afferent vagus nerve is an important component for transmitting peripheral immune signals to the brain, such as those determining interleukin (IL)-1b b expression in the brain and anorexia. In the present study, we investigated whether the anorexic effect of CCK, which also activates the afferent vagus nerve, is mediated via IL-1b b expression in the brain. CCK-8 dose-dependently (8-320 m mg/kg, i.p.) inhibited food intake in mice. However, IL-1b b transcripts in the hypothalamus, the hippocampus and the brainstem were not significantly increased after the administration of CCK-8, even at the larger dose of 320 m mg/kg. These findings suggest that the CCK-induced inhibition of food intake may be independent of IL-1b b production in the brain, and indicate the diverse role of CCK in the regulation of the neuro-immune interaction.
Interleukin (IL)-1b is a proinflammatory cytokine produced not only in the immune system but also in the brain. Peripheral or central application of IL-1b induces fever, 1) inhibition of food intake 2) and gastric acid secretion, 3, 4) and activation of the sympathetic 5) and hypothalamic-pituitaryadrenal (HPA) axis. 6, 7) The effects induced by IL-1b mimic those produced by bacterial endotoxin lipopolysaccharide (LPS).
1) The expression of IL-1b in the brain is highly inducible by peripherally applied LPS. 8) The afferent vagus nerve is known to be an important component for transmitting peripheral immune signals to the brain, such as IL-1b expression in the brain, 9) anorexia 10) and fever responses.
11)
We previously reported that direct electrical stimulation of the afferent vagus nerve induces IL-1b expression in the brain.
12)
The cholecystokinin (CCK) receptor has been reported to exist in the vagus nerve, 13) and CCK activates afferent vagus nerve activity. 14, 15) CCK-induced anorexia was suggested to be mediated by the vagus nerve because subdiaphragmatic vagotomy blocks the inhibitory effect of the intraperitoneal injection of CCK on food intake. 16) Increasing evidence has suggested that CCK is involved in immune-to-brain communication. 15, 17, 18) In the present study, since activation of the afferent vagus nerve is important for inducing IL-1b expression in the brain, we investigated the possibility that the anorexic effect of CCK, which activates the afferent vagus nerve, might be mediated via IL-1b expression in the brain.
MATERIALS AND METHODS
C57BL/6J mice were obtained at 7 weeks of age from the Central Laboratories for Experimental Animals (Japan). Mice were maintained in a room at 22-24°C under a constant day-night rhythm and were given food and water ad libitum. Mice were injected with saline or CCK-8 (CCK-8, Peptide Institute, Japan) after food deprivation from 16:00 to 10:00. Five minutes after saline or CCK-8 application, food intake was measured. For total RNA extraction, mice were killed by decapitation after intraperitoneal injection of CCK, and the brain was quickly removed. Total RNA was isolated, and RT-PCR was performed as described previously. 12, 19) The primers used were as follows: IL-1b upstream, 5Ј-aat ctc aca gca gca cat-3Ј; IL-1b downstream, 5Ј-agc cca tac ttt agg aag aca-3Ј; IL-1 receptor antagonist upstream, 5Ј-gac cct gca aga tgc aag cc-3Ј; and IL-1 receptor antagonist downstream, 5Ј-gag cgg atg aag gta aag cg-3Ј; glyceraldehydes-3-phosphate dehydrogenase (GAPDH) upstream, 5Ј-aaa ccc atc acc atc ttc cag-3Ј; and GAPDH downstream, 5Ј-agg ggc cat cca cag tct tct-3Ј. In the initial experiments, the amount of each amplified product was integrated and plotted graphically against the number of PCR cycles to determine whether the increase in intensity of the amplified product was linear to the number of PCR cycles. Each cycle of PCR produced a linear relation between the amount of input cDNA and the resulting PCR product. To compare the expression of IL-1b and IL-1 receptor antagonist mRNAs in the different experimental groups, the amount of IL-1b mRNA in each structure studied was estimated as the ratio of IL-1b/GAPDH and IL-1 receptor antagonist/GAPDH. Results were expressed as meansϮS.E. Statistical analysis was performed using a paired Student's ttest ( Fig. 1 ) and Dunnett's test for multiple comparison (Fig.  2) . Significant values are those with pϽ0.05 and pϽ0.01.
RESULTS AND DISCUSSION
CCK-8 produced a time and dose-dependent inhibition of food intake at 30 to 60 min after the administration (Fig. 1) . CCK-induced inhibition of food intake appeared to be short acting, with a peak effect at about 30 min. CCK-8-induced suppression of feeding was not observed 2 to 8 h after the administration, even at a larger dose of 320 mg/kg.
Subdiaphragmatic vagotomy has been shown to inhibit IL1b mRNA expression in the brain 2 h after the application of systemic IL-1b 20) or LPS. 21) Direct electrical stimulation of the afferent vagus nerve for 2 h induces IL-1b mRNA expression in the brain.
12) Therefore, CCK-8 was applied to mice, and IL-1b expressions in the brain were measured 2 h after the administration. IL-1b mRNA expressions in the hypothalamus, hippocampus and brainstem were not significantly affected by the application of CCK-8 (8, 32, 320 mg/kg, i.p.) (Fig. 2) . Furthermore, at an earlier time point of 45 min after the administration, CCK-8 (32 mg/kg, i.p.) did not significantly affect the IL-1b mRNA expression in the hypothalamus. The levels of IL-1b mRNA 45 min after the administration of saline and CCK-8 were 0.201Ϯ0.036, 0.189Ϯ0.022 (IL-1b/GAPDH), nϭ6, respectively. The IL-1 receptor antagonist in the brain is increased after brain ischemia or by lipopolysaccharide. 22 ,23) Therefore, we investigated the effect of CCK-8 on the expression of IL-1 receptor antagonist. CCK-8 (32 mg/kg, i.p.) did not significantly affect the expression of IL-1 receptor antagonist mRNA in the hypothalamus. The levels of IL-1 receptor antagonist mRNA after the administration of saline and CCK-8 were 0.596Ϯ0.045, 0.589Ϯ0.071 (IL-1 receptor antagonist/GAPDH), nϭ5, respectively. Thus, CCK may inhibit food intake independent of IL-1b production in the brain.
During peripheral inflammation, expression of IL-1b is induced in the brain, 8) and IL-1b induces symptoms of brainmediated illness.
1) CCK exhibits some similarity to IL-1b in its behavioral effects such behaviors as sleep, 24) anorexia, 24) and HPA axis activation. 25) Increasing evidence has suggested that CCK is involved in immune-to-brain communication. IL-1b was reported to sensitize the response of the gastric vagal afferent to CCK. 15) A peripheral injection of IL-1a increased plasma CCK and decreased food intake and gastric emptying, which was antagonized by pretreatment with a CCK receptor antagonist. 17) Furthermore, it was shown that CCK antagonists attenuated LPS-induced fever in rats. 18) CCK and LPS administration result in a similar activation of Fos protein or its mRNA in the brain, 26, 27) indicating the possibility that CCK participated in the inflammatory response. In contrast, it was reported that peripheral CCK receptors are not involved in the decrease of social exploration, 28) fever 29) or hypothalamic-pituitary-adrenal response 30) to pyrogens. Therefore, the exact mechanisms and interaction between the immune system and CCK is unclear. Since we could not observe CCK-induced IL-1b expression in the hypothalamus, the hippocampus or the brainstem, it is suggested that CCK activates behavioral effects independent of IL-1b production in the brain. CCK-8-induced inhibition of food intake ap- peared to be short acting, with the peak effect at about 30 min. The CCK-8-induced suppression of feeding was not observed 2 to 8 h after the administration, even at a larger dose of 320 mg/kg. Therefore, peripheral CCK may inhibit feeding via a rapid (such as neural) pathway rather than via a newly synthesized protein, such as IL-1b.
Peripherally applied IL-1b activates the vagal afferent nerve activity, 31) and systemic IL-1b has been shown to induce IL-1b mRNA expression in the brain via vagally mediated mechanisms. 20, 21) Since CCK is also known to induce the activation of afferent vagus nerve activity, 14, 15) we investigated whether the effect of CCK on inhibiting food intake is mediated through the induction of IL-1b expression in the brain. In the present study, however, we could not observe IL-1b expression in the brain when CCK was injected peripherally. These contrasting results suggest that two receptor populations for IL-1b and CCK may be localized on different neuronal populations of the vagus nerve. Indeed, ablation of the C-fiber type afferent by capsaicin pretreatment was not sufficient to inhibit the IL-1b-induced decrease in food motivated behavior, but was able to reduce CCK-induced anorexia. 32) Furthermore, using an in vitro single-unit electrophysiological study, two types of leptin-responsive gastric vagal afferent terminals have been observed. 33) Future anatomical studies need to examine whether IL-1b and the CCK receptors are localized on the same type of vagal afferent nerves; the results will provide further insights into the neural pathway utilized by IL-1b and CCK.
